SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICU (Captain)
Early Detection and Diagnostic Performance of Bio-markers During Bacterial Sepsis: Multicentre Cohort Study in Intensive Care
Sponsor: Assistance Publique - Hôpitaux de Paris
Listed as NCT01378169, this observational or N/A phase trial focuses on SIRS and Sepsis and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 13 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2023 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Sep 2023 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Completed NA
-
Aug 2017 — Nov 2017 [monthly]
Completed NA
-
Mar 2017 — Aug 2017 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Mar 2017 [monthly]
Unknown Status NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- BioMérieux
- Fondation Hôpital Saint-Joseph
- Institut Pasteur
For direct contact, visit the study record on ClinicalTrials.gov .